GLAXOSMITHKLINE LLC v. TEVA PHARMACEUTICALS USA, INC.
- CAFC Updates
- October 02, 2020
GlaxoSmithKline and SmithKline Beecham (collectively, “GSK”) charged Teva Pharmaceuticals with infringement of GSK’s Reissue Patent No. RE40,000 (“the ’000 patent”) directed to carvedilol...